Earnings History Data for Zai Lab Limited (ZLAB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	PM		ZLAB	Zai Lab Limited	3,050	-0.42	-0.75	-0.71	Zai Lab GAAP EPADS of -$0.42 beats by $0.36, revenue of $102.27M in-line [11/12/2024 6:36 AM]	29.00	-2.09 (-6.72%)	30.55	-0.54 (-1.74%)	13.48 - 36.60	912,481	800,000	14,726
Zai Lab Q3 2024 Earnings Preview [11/11/2024 1:34 PM] Zai Lab gets expanded Chinese approval for Vyvgart Hytrulo [11/11/2024 10:45 AM] Zai Lab GAAP EPADS of -$0.42 beats by $0.36, revenue of $102.27M in-line [11/12/2024 6:36 AM] Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates [2024-11-12 06:30AM] Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China [Nov-11-24 07:30AM] argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China [Nov-11-24 07:30AM]
06-08-2024	AH		ZLAB	Zai Lab Limited	1,830	-0.82	-0.66	-1.25	Zai Lab GAAP EPS of -$0.82 misses by $0.12, revenue of $100.5M beats by $7.36M [8/6/2024 4:24 PM]	16.81	-1.30 (-7.18%)	20.00	1.89 (10.44%)	13.48 - 31.22	1,074,144	670,000	10,472
Zai Lab ADR of -$0.82 misses by $0.12, revenue of $100.5M beats by $7.36M [8/6/2024 4:24 PM]
08-05-2024	AH		ZLAB	Zai Lab Limited	1,680	-0.55	-0.93	-0.51	Zai Lab GAAP EPADS of -$0.55 beats by $0.39, revenue of $87.15M beats by $11.91M [5/8/2024 4:35 PM]	21.09	4.52 (27.28%)	19.87	3.30 (19.92%)	13.48 - 39.50	3,402,430	510,000	109,923
Zai Lab GAAP EPADS of -$0.55 beats by $0.39, revenue of $87.15M beats by $11.91M [5/8/2024 4:35 PM]
27-02-2024	AH		ZLAB	Zai Lab Limited	1,970	-0.98	-0.87	-0.65	Zai Lab GAAP EPadS of -$3.46 beats by $0.01, revenue of $266.72M misses by $2.06M [2/27/2024 4:16 PM]	20.77	-1.72 (-7.65%)	22.00	-0.49 (-2.18%)	17.68 - 41.79	679,744	720,000	3,252
Zai Lab GAAP EPadS of -$3.46 beats by $0.01, revenue of $266.72M misses by $2.06M [2/27/2024 4:16 PM]
07-11-2023	AH		ZLAB	Zai Lab Limited	1,930	-0.71	-0.94	-1.68	Zai Lab GAAP EPS of -$0.71 beats by $0.27, revenue of $69.23M beats by $2.87M [11/7/2023 4:40 PM]	30.06	1.75 (6.18%)	29.62	1.31 (4.63%)	22.35 - 49.81	889,089	530,000	7,033
Zai Lab GAAP EPS of -$0.71 beats by $0.27, revenue of $69.23M beats by $2.87M [11/7/2023 4:40 PM]
07-08-2023	AH		ZLAB	Zai Lab Limited	2,720	-1.25	-0.74	-1.44	Zai Lab GAAP EPS of -$1.25 misses by $0.50, revenue of $68.86M misses by $1.81M [8/7/2023 4:42 PM]	24.20	-2.26 (-8.52%)	26.46	0.0 (0.00%)	20.98 - 53.95	820,026	390,000	2,908
Zai Lab GAAP EPS of -$1.25 misses by $0.50, revenue of $68.86M misses by $1.81M [8/7/2023 4:42 PM]
09-05-2023	AH	4:00 PM ET (May 9)	ZLAB	Zai Lab Limited	2,840	-0.51	-0.94	-0.86	Zai Lab GAAP EPS of -$0.05 beats by $0.88, revenue of $62.79M misses by $2.68M [5/9/2023 4:23 PM]	37.41	2.05 (5.80%)	35.36	0.0 (0.00%)	20.98 - 53.95	514,880	390,000	5,549
Zai Lab GAAP EPS of -$0.05 beats by $0.88, revenue of $62.79M misses by $2.68M [5/9/2023 4:23 PM]
01-03-2023	AH	4:00 PM ET (Mar 1)	ZLAB	Zai Lab Limited	2,750	-0.65	-1.04	-2.24	Zai Lab GAAP EPS of -$4.63 beats by $0.30, revenue of $215M misses by $1.4M [3/1/2023 4:23 PM]	37.06	-3.32 (-8.22%)	38.56	-1.82 (-4.51%)	20.98 - 53.95	1,093,783	510,000	3,614
Zai Lab GAAP EPS of -$4.63 beats by $0.30, revenue of $215M misses by $1.4M [3/1/2023 4:23 PM]
09-11-2022	AH	4:05 PM ET (Nov 9)	ZLAB	Zai Lab Limited	2,410	-1.68	-1.20	-1.01	Zai Lab GAAP EPS of -$0.17 beats by $1.10, revenue of $57.5M beats by $3.77M [11/9/2022 4:14 PM]	30.38	1.81 (6.34%)	31.00	2.43 (8.51%)	20.98 - 91.84	1,068,943	920,000	402
Zai Lab GAAP EPS of -$0.17 beats by $1.10, revenue of $57.5M beats by $3.77M [11/9/2022 4:14 PM] Zai Lab Announces Third Quarter 2022 Financial Results and Corporate Updates [Nov-09-22 04:01PM] Zai Lab to Present New Oncology Research at 2022 Society for Immunotherapy of Cancer Annual Meeting [Nov-08-22 08:30AM] Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer [Nov-08-22 07:30AM]
09-08-2022	AH	4:05 PM ET (Aug 9)	ZLAB	Zai Lab Limited	3,310	-1.44	-0.94	-1.76	Zai Lab GAAP EPS of -$0.14 beats by $0.92, revenue of $48.17M beats by $1.04M [8/9/2022 4:14 PM]	44.69	-0.52 (-1.15%)	44.36	-0.85 (-1.88%)	22.51 - 155.70	254,111	400,000	649
Zai Lab GAAP EPS of -$0.14 beats by $0.92, revenue of $48.17M beats by $1.04M [8/9/2022 4:14 PM] Why Earnings Season Could Be Great for Zai Lab (ZLAB) [Aug-08-22 01:07PM] Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia [Aug-08-22 07:02AM]
10-05-2022	AH	4:05 PM ET (May 10)	ZLAB	Zai Lab Limited	2,150	-0.86	-1.22	-2.64	Zai Lab GAAP EPS of -$0.09 beats by $1.05, revenue of $46.72M beats by $1M [5/10/2022 4:30 PM]	24.92	-1.32 (-5.03%)	29.60	3.36 (12.80%)	24.50 - 181.92	830,253	570,000	16,368
Zai Lab GAAP EPS of -$0.09 beats by $1.05, revenue of $46.72M beats by $1M [5/10/2022 4:30 PM] Zai Lab stock gains ~8% after Q1 earnings beat, strong product revenue growth [5/11/2022 10:32 AM] Zai Lab Announces First Quarter 2022 Financial Results and Corporate Updates [May-11-22 03:13AM] Zai Lab Announces First Quarter 2022 Financial Results and Corporate Updates [May-10-22 04:01PM]
01-03-2022	AH	4:10 PM ET (Mar 1)	ZLAB	Zai Lab Limited	4,070	-2.24	-1.66	0.00	Zai Lab GAAP EPS of -$7.58 misses by $0.73, revenue of $144.3M misses by $3.91M [3/1/2022 4:46 PM]	52.34	-0.21 (-0.40%)	50.98	-1.57 (-2.99%)	39.75 - 181.92	1,660,313	620,000	1,617
Zai Lab GAAP EPS of -$7.58 misses by $0.73, revenue of $144.3M misses by $3.91M [3/1/2022 4:46 PM] Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021 [Mar-01-22 04:05PM]
09-11-2021	AH	4:30 PM ET (Nov 9)	ZLAB	Zai Lab Limited	7,740	-1.01	-1.24	0.00	Zai Lab EPS beats by $0.23, misses on revenue [11/9/2021 4:35 PM]	87.99	1.30 (1.50%)	87.33	0.64 (0.74%)	83.52 - 193.54	525,466	650,000	27,974
Karuna Therapeutics, Zai Lab team up for experimental psychiatric therapy in China [11/9/2021 8:19 AM] Zai Lab EPS beats by $0.23, misses on revenue [11/9/2021 4:35 PM] Is Zai Lab (ZLAB) A Smart Investment Choice? [Nov-08-21 12:44PM] Zai Lab and Karuna Therapeutics Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China [Nov-09-21 07:00AM] PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China [Nov-09-21 07:37AM] Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China [Nov-09-21 08:00AM] Blueprint Medicines and Zai Lab Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China [Nov-09-21 08:00AM] Zai Lab Announces Third Quarter 2021 Financial Results and Corporate Updates [Nov-09-21 04:10PM]
09-08-2021	AH	After the close (Aug 9)	ZLAB	Zai Lab Limited	10,900	-1.76	-1.55	0.00	Zai Lab EPS misses by $0.37, beats on revenue [8/9/2021 4:33 PM]	149.76	-4.26 (-2.77%)	154.02	0.0 (0.00%)	72.42 - 193.54	284,902	1,050,000	77,030
Zai Lab EPS misses by $0.37, beats on revenue [8/9/2021 4:33 PM] Zai Lab Announces Second Quarter 2021 Financial Results and Corporate Updates [Aug-09-21 04:30PM]
10-05-2021	PM	7:30 AM ET (May 10)	ZLAB	Zai Lab Limited	12,140	-2.64	-0.86	0.00	Zai Lab EPS misses by $1.78, beats on revenue [5/10/2021 7:40 AM]	149.45	-8.69 (-5.50%)	158.14	0.0 (0.00%)	62.89 - 193.54	676,643	570,000	2,978
Zai Lab EPS misses by $1.78, beats on revenue [5/10/2021 7:40 AM] Zai Lab Announces First Quarter 2021 Financial Results [May-10-21 07:32AM]
01-03-2021	PM	7:30 AM ET (Mar 1)	ZLAB	Zai Lab Limited	13,220	N/A	0.00	-0.68	Zai Lab EPS misses by $0.35, misses on revenue [3/1/2021 7:15 AM]	161.86	14.34 (9.72%)	147.50	-0.02 (-0.01%)	43.06 - 193.54	342,289	403,417	265
Zai Lab EPS misses by $0.35, misses on revenue [3/1/2021 7:15 AM]